Overview

A Trial of HR021618 in Postsurgical Pain Management

Status:
Active, not recruiting
Trial end date:
2021-08-08
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, safety of HR021618 and to explore the reasonable dosage of HR021618 for Pain Management after Orthopaedic surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.